DTL
ESPR

Dynamic Technology Lab’s Esperion Therapeutics ESPR Stock Holding History

Dynamic Technology Lab’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-17,007
Closed -$38K – 1108
2024
Q2 		$38K Buy
+17,007
New +$40K ﹤0.01% 889
2023
Q2 		– Sell
-36,699
Closed -$58K – 1107
2023
Q1 		$58K Buy
36,699
+20,946
+133% +$108K 0.01% 1001
2022
Q4 		$98K Buy
+15,753
New +$113K 0.01% 996
2022
Q2 		– Sell
-15,598
Closed -$72K – 1246
2022
Q1 		$72K Sell
15,598
-972
-6% -$4.17K 0.01% 1024
2021
Q4 		$83K Buy
+16,570
New +$133K 0.01% 1045
2019
Q3 		– Sell
-8,580
Closed -$399K – 1043
2019
Q2 		$399K Buy
8,580
+390
+5% +$18.3K 0.07% 508
2019
Q1 		$329K Buy
+8,190
New +$367K 0.05% 620
2017
Q4 		– Sell
-14,110
Closed -$707K – 1085
2017
Q3 		$707K Buy
+14,110
New +$680K 0.11% 299

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Dynamic Technology Lab's ESPR Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Esperion Therapeutics (ESPR) in Q3 2024, closing a stake of 17,007 shares — an estimated $38K sold.

Dynamic Technology Lab first reported a position in ESPR in Q3 2017 and held it in 8 quarters. The position peaked at $707K in Q3 2017. 183 funds tracked by Wall St. Rank hold ESPR as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Esperion Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 17,007 Esperion Therapeutics shares in Q3 2024, an estimated $38K.
  • Dynamic Technology Lab first reported a position in Esperion Therapeutics in Q3 2017 and held it in 8 quarters.
  • Dynamic Technology Lab's Esperion Therapeutics position peaked at $707K in Q3 2017.
  • 183 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.